Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Atsushi HiraokaTakashi KumadaMasanori AtsukawaMasashi HirookaKunihiko TsujiToru IshikawaKoichi TakaguchiKazuya KariyamaEi ItobayashiKazuto TajiriNoritomo ShimadaHiroshi ShibataHironori OchiToshifumi TadaHidenori ToyodaKazuhiro NousoAkemi TsutsuiTakuya NaganoNorio ItokawaKorenobu HayamaMichitaka ImaiKouji JokoYohei KoizumiYoichi HiasaKojiro MichitakaMasatoshi Kudonull null

Published in: Cancer medicine (2019)

Good hepatic function (mALBI 1/2a) is the best indication for LEN, while potential appetite loss in association with low BMI should be kept in mind in such cases.

Keyphrases

prognostic factors
body mass index
weight loss
locally advanced
cross sectional
clinical trial
squamous cell carcinoma
physical activity
risk assessment